Communications for Statistical Applications and Methods

The Korean Statistical Society (한국통계학회)
권호 표지

A Bayes Test for Equality of Intra-Subject Variabilities in 2$\times$2 Crossover Design

  • Published : 2000.08.01
Download PDF
⟨ Previous Next ⟩

Abstract

Various statistical methods for assessment of equivalence in average bioavailabilities have been developed under the assumption that the intra-subject variabilities for the test and reference formulations are the same. Without the assumption, assessing the equivalence in average bioavailabilites does not imply that the two formulations are therapeutically equivalent and exchangeable. The most commonly used test procedure for equality of variabilites in 2$\times$2 crossover experiment is the so called Pitman-Morgan's adjusted F test based on the model without carryover effects (Chow and Liu(1992)). In this paper, a Bayesian method based on the Intrinsic Bayes Factor is proposed, which can be applied to the model with carryover effects.

Keywords

References

  1. J. of Pharmacokin and Biopharm v.18 Consideration of individual bioeqivalence Anderson,S.;Hauck,W.W.
  2. Statistical Decision Theory and Bayesian Analysis Berger,J.O.
  3. Journal of the American Statistical Association v.91 The intrinsic Bayes Factor for model selection and prediction Berger,J.O.;Pericchi,L.R.
  4. Design and analysis of bioavailability and bioequivalence studies Chow,S.C.;Liu,J.P.
  5. Biometrics v.41 A Bayesian analysis of the two-period crossover design for clinical trials Grieve,A.P.
  6. Corrigenda in Biometrics v.30 The two-period change-over design and its use in clinical trial Grizzle,J.E.
  7. Journal of Pharmacutical Sciences v.70 Statistical simulation study of new proposed uniformit requirement for bioequivalency studies Haynes,J.D.
  8. British Journal of Clinical Pharmacology v.8 The two-period corss-over clinical trial Hills,M.;Armitage,P.
  9. Design and Analysis of Crossover Trials Jones,B.;Kenward,M.G.
  10. Journal of the Korean Statistical Society v.26 A prdictive two-group multinormal classification rule accounting for model uncertainty Kim,H.J.
  11. The Korean Communications in Statistics v.6 Assessment and interpretation on bioequivalence for two drug formulations using crossover design Ko,S.G.;Oh,H.S.
  12. Communications in Statistics-Theory and Methods v.21 no.9 On the assessment of variablitity in bioavailability/bioequivalence studies Liu,J.P.;Chow,S.C.
  13. The Korean Journal of Applied Statistics v.12 Assessing bioequivalence with two new drug formulations and a reference formulation Oh,H.S.;Ko,S.G.;Kim,J.I.;Park,S.G.
  14. Journal of the Royal Statistical Society, Ser. B v.44 Bayes Factors for linear and log-linear models with vague prior information Spiegelhalter,D.J.;Smith,A.F.M.